Therefore, we believe that AKT1, MAPK3, and their corresponding binding active components in CSS (e.g., luteolin) play critical roles in HCC, and it is necessary to study the interaction between them as well as their potential link with HCC. This evidence concerns the gene MAPK3 and hepatocellular carcinoma.